A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins-Reference-Cited by-同舟云学术

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

Published:2015-02-20 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Fibriansah Guntur,Tan Joanne L.,Smith Scott A.,de Alwis Ruklanthi,Ng Thiam-Seng,Kostyuchenko Victor A.,Jadi Ramesh S.,Kukkaro Petra,de Silva Aravinda M.,Crowe James E.,Lok Shee-Mei

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7341.pdf

Reference58 articles.

1. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).

2. Thomas, S. J. & Endy, T. P. Critical issues in dengue vaccine development. Curr. Opin. Infect. Dis. 24, 442–450 (2011).

3. Higa, Y. Dengue vectors and their spatial distribution. Trop. Med. Health 39, 17–27 (2011).

4. Holmes, E. & Twiddy, S. The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. Evol. 3, 19–28 (2003).

5. Vasilakis, N. & Weaver, S. C. The history and evolution of human dengue emergence. Adv. Virus Res. 72, 1–76 (2008).

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curvature Footprints of Transmembrane Proteins in Simulations with the Martini Force Field;The Journal of Physical Chemistry B;2024-06-11

2. Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein;Vaccine;2024-04

3. The Dynamic Landscape of Capsid Proteins and Viral RNA Interactions in Flavivirus Genome Packaging and Virus Assembly;Pathogens;2024-01-28

4. Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine;Vaccines;2024-01-17

5. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS;Pathogens;2023-12-22